Search

Duc T. Duong

Examiner (ID: 7909, Phone: (571)272-3122 , Office: P/2467 )

Most Active Art Unit
2467
Art Unit(s)
2663, 2467, 2419, 2619, 2616
Total Applications
1201
Issued Applications
977
Pending Applications
137
Abandoned Applications
108

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16376315 [patent_doc_number] => 20200325157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => Novel Thiophene Compounds for Long-Acting Injectable Compositions and Related Methods [patent_app_type] => utility [patent_app_number] => 16/674040 [patent_app_country] => US [patent_app_date] => 2019-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16674040 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/674040
Thiophene compounds for long-acting injectable compositions and related methods Nov 4, 2019 Issued
Array ( [id] => 15589501 [patent_doc_number] => 20200071285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => CONTINUOUS ISOLATION OF CANNABIDIOL AND CONVERSION OF CANNABIDIOL TO DELTA 8-TETRAHYDROCANNABINOL AND DELTA 9-TETRAHYDROCANNABINOL [patent_app_type] => utility [patent_app_number] => 16/672047 [patent_app_country] => US [patent_app_date] => 2019-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16672047 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/672047
Continuous isolation of cannabidiol and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol Oct 31, 2019 Issued
Array ( [id] => 15831729 [patent_doc_number] => 20200131146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => APPARATUS AND METHOD FOR REMOVING A COMPONENT FROM A SOLUTION [patent_app_type] => utility [patent_app_number] => 16/661308 [patent_app_country] => US [patent_app_date] => 2019-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5207 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661308 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/661308
Apparatus and method for removing a component from a solution Oct 22, 2019 Issued
Array ( [id] => 19651227 [patent_doc_number] => 12172995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-24 [patent_title] => Substituted indole and indazole compounds [patent_app_type] => utility [patent_app_number] => 17/287612 [patent_app_country] => US [patent_app_date] => 2019-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22821 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287612 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/287612
Substituted indole and indazole compounds Oct 21, 2019 Issued
Array ( [id] => 19504952 [patent_doc_number] => 12116363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-15 [patent_title] => Combinations for immune-modulation in cancer treatment [patent_app_type] => utility [patent_app_number] => 16/657477 [patent_app_country] => US [patent_app_date] => 2019-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6194 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16657477 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/657477
Combinations for immune-modulation in cancer treatment Oct 17, 2019 Issued
Array ( [id] => 15768701 [patent_doc_number] => 20200115368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => INHIBITING FATTY ACID SYNTHASE (FASN) [patent_app_type] => utility [patent_app_number] => 16/598481 [patent_app_country] => US [patent_app_date] => 2019-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598481 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/598481
Inhibiting fatty acid synthase (FASN) Oct 9, 2019 Issued
Array ( [id] => 15435309 [patent_doc_number] => 20200031838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => Process for Making Beta 3 Agonists and Intermediates [patent_app_type] => utility [patent_app_number] => 16/590180 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9632 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16590180 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/590180
Process for making beta 3 agonists and intermediates Sep 30, 2019 Issued
Array ( [id] => 16549709 [patent_doc_number] => 10882858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer [patent_app_type] => utility [patent_app_number] => 16/584996 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25706 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584996 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/584996
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer Sep 26, 2019 Issued
Array ( [id] => 15681133 [patent_doc_number] => 20200095230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 16/586401 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16586401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/586401
SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS Sep 26, 2019 Abandoned
Array ( [id] => 15363395 [patent_doc_number] => 20200017462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => NIRAPARIB COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/584401 [patent_app_country] => US [patent_app_date] => 2019-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/584401
Niraparib compositions Sep 25, 2019 Issued
Array ( [id] => 15363395 [patent_doc_number] => 20200017462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => NIRAPARIB COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/584401 [patent_app_country] => US [patent_app_date] => 2019-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/584401
Niraparib compositions Sep 25, 2019 Issued
Array ( [id] => 15363395 [patent_doc_number] => 20200017462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => NIRAPARIB COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/584401 [patent_app_country] => US [patent_app_date] => 2019-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/584401
Niraparib compositions Sep 25, 2019 Issued
Array ( [id] => 15363395 [patent_doc_number] => 20200017462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => NIRAPARIB COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/584401 [patent_app_country] => US [patent_app_date] => 2019-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584401 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/584401
Niraparib compositions Sep 25, 2019 Issued
Array ( [id] => 17156058 [patent_doc_number] => 20210317109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND [patent_app_type] => utility [patent_app_number] => 17/274206 [patent_app_country] => US [patent_app_date] => 2019-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274206 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/274206
TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND Sep 8, 2019 Abandoned
Array ( [id] => 15615903 [patent_doc_number] => 20200078356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES [patent_app_type] => utility [patent_app_number] => 16/562942 [patent_app_country] => US [patent_app_date] => 2019-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10179 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562942 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/562942
Neuroprotective agents for treatment of neurodegenerative diseases Sep 5, 2019 Issued
Array ( [id] => 17323549 [patent_doc_number] => 11214543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Process for the preparation of Lenvatinib [patent_app_type] => utility [patent_app_number] => 17/273740 [patent_app_country] => US [patent_app_date] => 2019-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1965 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273740 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/273740
Process for the preparation of Lenvatinib Sep 2, 2019 Issued
Array ( [id] => 15598661 [patent_doc_number] => 20200075865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => SEMICONDUCTING CO-POLYMERS OF METHYLENEDIHYDROPYRAZINES WITH FUSED THIOPHENES [patent_app_type] => utility [patent_app_number] => 16/555548 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555548 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/555548
Semiconducting co-polymers of methylenedihydropyrazines with fused thiophenes Aug 28, 2019 Issued
Array ( [id] => 19904312 [patent_doc_number] => 12281308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Inhibition of protein kinases to treat Friedreich ataxia [patent_app_type] => utility [patent_app_number] => 17/265466 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12639 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265466 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/265466
Inhibition of protein kinases to treat Friedreich ataxia Aug 28, 2019 Issued
Array ( [id] => 19793278 [patent_doc_number] => 12234207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-25 [patent_title] => Halo-(3-(phenylsulfonyl)prop-1-enyl)pyridine derivative and use thereof [patent_app_type] => utility [patent_app_number] => 17/268958 [patent_app_country] => US [patent_app_date] => 2019-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12910 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17268958 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/268958
Halo-(3-(phenylsulfonyl)prop-1-enyl)pyridine derivative and use thereof Aug 18, 2019 Issued
Array ( [id] => 15451123 [patent_doc_number] => 20200038385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => S1P MODULATING AGENTS [patent_app_type] => utility [patent_app_number] => 16/542746 [patent_app_country] => US [patent_app_date] => 2019-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16542746 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/542746
S1P modulating agents Aug 15, 2019 Issued
Menu